METASTATIC CUTANEOUS MELANOMA
Clinical trials for METASTATIC CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo shows promise for Tough-to-Treat cancers
Disease control CompletedThis study tested whether combining two drugs, brentuximab vedotin and pembrolizumab, can shrink tumors in people with advanced melanoma, lung cancer, or head and neck cancer that has spread. About 161 adults took part. The main goal was to see how many patients had their tumors …
Matched conditions: METASTATIC CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Own immune cells delivered to liver to fight melanoma
Disease control CompletedThis early-phase trial tested whether it is safe and feasible to give patients their own immune cells (called tumor infiltrating lymphocytes, or TIL) directly into the liver artery. Eight adults with melanoma that had spread to the liver received the TIL infusion along with chemo…
Matched conditions: METASTATIC CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC